Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil.
Surgical resection with partial hepatectomy is the treatment of choice in patients with hepatocellular carcinoma (HCC). However, after recurrence, which is common, such patients have limited therapeutic options. In the present report, transarterial radionuclide therapy (TART) with rhenium 188 HDD-labeled Lipiodol was used to treat a patient with postsurgical recurrence of HCC. The patient tolerated therapy well and the lesions were completely ablated with a single dose of 188Re; the patient is free of disease for 14 months. TART with 188Re-HDD Lipiodol appears to be a promising new therapy in case of HCC recurrence after partial hepatectomy and requires further investigation.
Kumar
Ajay
A
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India. kumar_drajay@rediffmail.com
Srivastava
Deep N
DN
Bal
Chandrasekhar
C
D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000532:radiotherapy*; D003287:Contrast Media / Q000627:therapeutic use*; D006801:Humans; D007459:Iodized Oil / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000532:radiotherapy*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D011379:Prognosis; D011868:Radioisotopes / Q000627:therapeutic use*; D012211:Rhenium / Q000627:therapeutic use*
D003287:Contrast Media; D011868:Radioisotopes; D012211:Rhenium; D007459:Iodized Oil